Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

Running, not enrolling · Phase 3

Conditions studied: Motion Sickness

In brief

An open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travel

Key facts

Study ID

NCT06138613

Run by

Vanda Pharmaceuticals

People needed

705

Starts

2023-02-27

Expected to finish

2027-12-30

Last updated by the study team

2026-04-16

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of Motion Sickness
• Age 18-75

You may not qualify if…

• Nausea-inducing disorder other than motion sickness
• BMI > 40
• History of intolerance and/or hypersensitivity to Neurokinin-1 Receptor antagonists

Where it is running

• Santa Monica Clinical Trials — Santa Monica, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.